Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles
  2. Tarasov, S. G.; Gaponenko, V.; Howard, O. M. Z.; Chen, Y. H.; Oppenheim, J. J.; Dyba, M. A.; Subramaniam, S.; Lee, Y.; Michejda, C.; Tarasova, N. I.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jun; 108(24): 9798-9803.
  1. 2.   Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502)
  2. Hariprakasha, H. K.; Kosakowska-Cholody, T.; Meyer, C.; Cholody, W. M.; Stinson, S. F.; Tarasova, N. I.; Michejda, C. J.
  3. Journal of Medicinal Chemistry. 2007, Nov; 50(23): 5557-5560.
  1. 3.   Synthesis and biological activity of 5-aza-ellipticine derivatives
  2. Moody, D. L.; Dyba, M.; Kosakowska-Cholody, T.; Tarasova, N. I.; Michejda, C. I.
  3. Bioorganic & Medicinal Chemistry Letters. 2007, Apr; 17(8): 2380-2384.
  1. 4.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 5.   A new synthetic agent with potent but selective cytotoxic activity against cancer
  2. Cholody, W. M.; Kosakowska-Cholody, T.; Hollingshead, M. G.; Hariprakasha, H. K.; Michejda, C. J.
  3. Journal of Medicinal Chemistry. 2005, JUN 30; 48(13): 4474-4481.
  1. 6.   Bisimidazoacridones induce a potent cytostatic effect in colon tumor cells that sensitizes them to killing by UCN-01
  2. Cholody, W. M.; Kosakowska-Cholody, T.; Michejda, C. J.
  3. Cancer Chemotherapy and Pharmacology. 2001 47(3): 241-249.
  1. 7.   Inhibition of Acute-, Latent-, and Chronic-Phase Human Immunodeficiency Virus Type 1 (Hiv-1) Replication By a Bistriazoloacridone Analog That Selectively Inhibits Hiv-1 Transcription
  2. Turpin, J. A.; Buckheit, R. W.; Derse, D.; Hollingshead, M.; Williamson, K.; Palamone, C.; Osterling, M. C.; Hill, S. A.; Graham, L.; Schaeffer, C. A.; Bu, M.; Huang, M. J.; Cholody, W. M.; Michejda, C. J.; Rice, W. G.
  3. Antimicrobial Agents and Chemotherapy. 1998 42(3): 487-494.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel